oxybutynin has been researched along with Autonomic Hyperreflexia in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Following a 7-day washout period, patients were evaluated via video-urodynamic study and then treatment was initiated at a dosage of 10 mg per day." | 2.71 | Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury. ( Chancellor, MB; Erickson, JR; Horton, J; McDermott, C; O'Leary, M; Smith, CP, 2003) |
| "Accelerated intravesical administration results in greater bioavailability and increased objective benefits without side effects in previously unresponsive patients compared with oral and intravesical passive diffusion oxybutynin administration." | 2.70 | Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens. ( Capelli, G; Di Stasi, SM; Giannantoni, A; Massoud, R; Navarra, P; Stephen, RL; Vespasiani, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Leary, M | 1 |
| Erickson, JR | 1 |
| Smith, CP | 1 |
| McDermott, C | 1 |
| Horton, J | 1 |
| Chancellor, MB | 1 |
| Di Stasi, SM | 1 |
| Giannantoni, A | 1 |
| Vespasiani, G | 1 |
| Navarra, P | 1 |
| Capelli, G | 1 |
| Massoud, R | 1 |
| Stephen, RL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-Blind, Randomized Study of the Safety and Efficacy of OnabotulinumtoxinA (OnaBoNT-A) Versus Oral Oxybutynin in Spinal Cord Injured Patients With Neurogenic Detrusor Overactivity (Protocol Number 11-09-10-04)[NCT01050114] | Phase 3 | 36 participants (Anticipated) | Interventional | 2013-08-31 | Recruiting | ||
| Incobotulinumtoxin Versus Onabotulinumtoxin in the Treatment of Patients With Overactive Bladder Syndrome[NCT03758235] | Phase 3 | 140 participants (Actual) | Interventional | 2018-09-01 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for oxybutynin and Autonomic Hyperreflexia
| Article | Year |
|---|---|
Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.
Topics: Adult; Aged; Autonomic Dysreflexia; Delayed-Action Preparations; Dose-Response Relationship, Drug; F | 2003 |
Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens.
Topics: Administration, Intravesical; Adolescent; Adult; Autonomic Dysreflexia; Cholinergic Antagonists; Ele | 2001 |